Rezolute share price logo

Rezolute

NASDAQ: RZLT

Small Cap

$4.71

+0.05

(+1.07%)

as on

Rezolute Stock Performance

as on August 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.65
    $4.87
    downward going graph

    1.27%

    Downside

    3.40%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.07
    $11.46
    downward going graph

    77.28%

    Downside

    143.24%

    Upside

    downward going graph

Rezolute share price movements today

Previous Close
$4.66
Open
$4.77
Volume
1.2M
Market Cap
$442.9M
Day's Low - High
$4.65 - $4.87
52 Week Low - High
$1.07 - $11.46

Rezolute Historical Returns

1 Month Return
-0.22 %
3 Month Return
+ 37.72 %
1 Year Return
-29.23 %
3 Year Return
+ 208.72 %
5 Year Return
-55.6 %

Rezolute Stock Fundamentals & Key Indicators

Check Rezolute market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$442.9M

EPS (TTM)

-0.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.61

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.15797060127736295

EBITDA

-81.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-58.82%

Rezolute Stock Valuation

Track how Rezolute P/E has moved over time to understand its valuation trends.

Rezolute in the last 5 years

  • Overview

  • Trends

Lowest (-5.24x)

June 30, 2021

Industry (-7.28x)

June 30, 2025

Today (-4.55x)

June 30, 2025

Highest (-1.43x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.55x

Rezolute vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rezolute with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$442.9M-55.6%-5.610.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Rezolute Stock including INR - Dollar returns

The Rezolute stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Rezolute investment value today

Current value as on today

₹79,679

Returns

-₹20,321

(-20.32%)

Returns from Rezolute Stock

-₹27,538 (-27.54%)

Dollar Impact

₹7,218 (+7.22%)

Analyst Recommendation on Rezolute Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Rezolute. Average target price of $7.67

Rezolute Share Price Target

Get share price movements and forecasts by analysts on Rezolute.

What analysts predicted

38.59%UPSIDE

Target Price

$7.67

Current Price

$4.71

Analyzed by

8 Analysts

Target

$7.67

Rezolute target price $7.67, a slight upside of 38.59% compared to current price of $4.71. According to 8 analysts rating.

Indian Investors' Interest in Rezolute Stock

Search interest for Rezolute Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Rezolute Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
0
0
0
Operating Income
-15
-16
-23
-16
-17
-20
-25
-19
-24
-17
EBITDA
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rezolute Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-12
-1
0
0
0
-
-
-
-
Operating Income
-20
-28
-25
-20
-22
-41
-55
-70
-79
EBITDA
-19
-28
-25
-20
-20
-39
-51
-68
-74
Interest Expense
0
0
4
-
0
1
-
-
-
Depreciation
1
1
0
0
0
0
0
0
0
Income Before Tax
-20
-29
-30
-20
-20
-41
-51
-68
-74
Income Tax Expense
0
-
0
-
-
-
-
-
-
Net Income
-20
-29
-30
-20
-20
-41
-51
-68
-74
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rezolute Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Operating Cash Flow
-13
-15
-18
-16
-13
-17
-21
-17
-20
-13
Investing Cash Flow
17
8
19
-49
11
23
0
-68
22
12
Financing Cash Flow
0
0
63
5
0
0
101
0
0
0
Change in Cash
4
-6
64
-59
-1
5
79
-85
2
0

Rezolute Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-20
-29
-30
-20
-20
-41
-51
-68
-74
Operating Cash Flow
-13
-14
-15
-24
-20
-39
-44
-57
-69
Investing Cash Flow
0
1
0
-
-
-
-101
48
-14
Financing Cash Flow
13
9
25
22
51
148
11
63
107
Change in Cash
0
-2
9
-1
31
109
-134
54
23

Mutual Funds that own Rezolute Stock

Check out the Mutual Funds with significant holdings in Rezolute.

Funds
Holdings
Shares Held
Federated Hermes Equity Funds
21.66264%
20859461
VANGUARD INDEX FUNDS
3.575121%
3442568
VANGUARD HORIZON FUNDS
1.024431%
986449
Fidelity Concord Street Trust
0.889732%
856744
Fidelity Salem Street Trust
0.824111%
793556

Global Institutional Holdings in Rezolute

Funds
Holdings
Peter Kolchinsky
9.53%
Vanguard
4.98%
iShares
3.27%
Stephen A. Schwarzman
3.14%
Michael Rockefeller
0.64%

Rezolute News & Key Events

  • img

    Today's Timeline - 11 December

    Thu, 11:03 PM

    -

    Rezolute's Phase 3 trial for ersodetug fails, leading to a 90% stock price drop.

Insights on Rezolute

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RZLT stock has moved up by 44.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 416.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 497.3% return, outperforming this stock by 527.3%

About Rezolute

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
OrganisationRezolute
Headquarters275 Shoreline Drive, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEOMr. Nevan Charles Elam J.D.
E-voting on sharesClick here to vote

Key Management of Rezolute

Name

Title

Dr. Davelyn Eaves Hood M.B.A., M.D.

Director and Head of Scientific & Patient Affairs

Mr. Michael Covarrubias

Senior VP & Head of Program & Portfolio Management

Ms. Robyn Sweinhart

VP & Head of Quality

Mr. Daron G. Evans M.B.A., M.S.

Chief Financial & Business Officer

Dr. Brian Kenneth Roberts M.D.

Chief Medical Officer

Mr. Michael R. Deperro

Senior VP & Head of Operations

Dr. Raj Agrawal M.D.

VP & Head of Ophthalmological Clinical Development

Mr. Nevan Charles Elam J.D.

Founder, CEO, Principal Financial Officer & Acting Chairman of the Board

Ms. Melissa Quinn

Senior Director of People and Culture

Mr. Chris Milks

VP & Head of Finance

FAQs

What is Rezolute share price today?

Rezolute share price today is $4.71 as on at the close of the market. Rezolute share today touched a day high of $4.87 and a low of $4.65.

What is the 52 week high and 52 week low for Rezolute share?

Rezolute share touched a 52 week high of $11.46 on and a 52 week low of $1.07 on . Rezolute stock price today i.e. is closed at $4.71,which is 58.89% down from its 52 week high and 340.19% up from its 52 week low.

What is Rezolute's market capitalisation today?

Rezolute market capitalisation is $0.00T as on .

How to invest in Rezolute Stock (RZLT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rezolute on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rezolute Shares that will get you 0.3185 shares as per Rezolute share price of $4.71 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Rezolute Stock (RZLT) from India?

Indian investors can start investing in Rezolute (RZLT) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Rezolute stock (as per the Rupee-Dollar exchange rate as on ). Based on Rezolute share’s latest price of $4.71 as on August 20, 2026 at 1:29 am IST, you will get 2.1231 shares of Rezolute. Learn more about fractional shares .

What are the returns that Rezolute has given to Indian investors in the last 5 years?

Rezolute stock has given -55.6% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?